FRAXLANZA

What this means for you

Not registered yet, but its 10 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98743154

Mark type

Stylized text

Filed

10 Sept 2024

Published for opposition

08 Apr 2025

Attorney of record

Keith Toms, Esq.

Goods and services

• Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy; pharmaceutical preparations for frataxin replacement therapy

Owner

• Larimar Therapeutics, Inc., Bala Cynwyd, PA, US
• Larimar Therapeutics, Inc., Bala Cynwyd, PA, US

Prosecution history

• 02 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 01 Dec 2025 — SOU EXTENSION 1 GRANTED
• 01 Dec 2025 — SOU EXTENSION 1 FILED
• 01 Dec 2025 — SOU TEAS EXTENSION RECEIVED
• 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 08 Apr 2025 — PUBLISHED FOR OPPOSITION
• 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 17 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 17 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
• 17 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 17 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
• 17 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
• 12 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 12 Mar 2025 — NON-FINAL ACTION E-MAILED